(4S)-5-((2aR,4S,4aS,6R,9S,11S,12S,12aR,12bS)-12b-acetoxy-12-(benzoyloxy)-11-hydroxy-4a,8,13,13-tetramethyl-5-oxo-4,6-bis(((2,2,2-trichloroethoxy)carbonyl)oxy)-2a,3,4,4a,5,6,9,10,11,12,12a,12b-dodecahydro-1H-7,11-methanocyclodeca[3,4]benzo[1,2-b]oxet-9-yl) 3-tert-butyl 2,2-dimethyl-4-phenyloxazolidine-3,5-dicarboxylate
Cabazitaxel Impurity 35 (DiTroc-oxazolidine) is a fully characterized chemical compound used as a reference standard of API Cabazitaxel. The standard offered is compliant with regulatory guidelines. Cabazitaxel Impurity 35 (DiTroc-oxazolidine) is used for analytical method development, method validation (AMV), and Quality Controlled (QC) applications during synthesis and formulation stages of drug development and serves as a reference standard for traceability against pharmacopeial standards (USP or EP). Axios Research products are intended for analytical purposes only and are not for human use. CAS -
